PETX Insider Trading Activity and SEC Form 4 Filings
PETX insider trading summary
No open-market insider purchases or sales of Aratana Therapeutics, Inc. (PETX) have been reported on SEC Form 4 in the past 12 months.
Latest PETX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 30, 2019 | John C Ayres | See Remarks | Sell | $13K (3,125 @ $4.19) |
| Dec 17, 2018 | Peter Steven St | President and CEO | Sell | $270K (46,094 @ $5.85) |
| Nov 7, 2018 | Ernst Heinen | Chief Development Officer | Sell | $134K (19,308 @ $6.95) |
| Nov 2, 2018 | Ernst Heinen | Chief Development Officer | Sell | $5K (692 @ $6.95) |
| Oct 30, 2018 | Peter Steven St | President and CEO | Sell | $67K (11,513 @ $5.86) |
| Sep 21, 2018 | Peter Steven St | President and CEO | Sell | $454K (75,000 @ $6.06) |
| Aug 14, 2018 | Ernst Heinen | Chief Development Officer | Sell | $9K (1,712 @ $5.15) |
| Aug 13, 2018 | Ernst Heinen | Chief Development Officer | Sell | $45K (8,660 @ $5.15) |
| Aug 10, 2018 | Ernst Heinen | Chief Development Officer | Sell | $10K (1,954 @ $5.15) |
| Aug 8, 2018 | Ernst Heinen | Chief Development Officer | Sell | $14K (2,674 @ $5.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.